U.S. Machinery Stock News

NasdaqGS:ARQT
NasdaqGS:ARQTBiotechs

Arcutis Biotherapeutics (ARQT) Could Be 31% Undervalued Following Profit And Higher Guidance

Arcutis Biotherapeutics (ARQT) is back on investor radars after second quarter 2026 results showed revenue of $129.86 million, net income of $15.01 million, and raised full year net product sales guidance. See our latest analysis for Arcutis Biotherapeutics. The latest results and raised full year guidance have come alongside a 19.07% 3 month share price return and a 71.23% 1 year total shareholder return. However, shorter term share price returns over the past month and year to date have...
NYSE:AVY
NYSE:AVYPackaging

Avery Dennison (AVY) Lifted Its Guidance, Is The Stock Still Cheap?

Why Avery Dennison Stock Is Back in Focus After Q2 Avery Dennison (AVY) is drawing fresh attention after reporting higher Q2 2026 sales and net income, lifting its full-year earnings guidance, continuing its share buyback program, and declaring a new cash dividend. See our latest analysis for Avery Dennison. Avery Dennison’s recent Q2 earnings beat, higher full year guidance, share buybacks and the new dividend have coincided with a 10.25% 1 month share price return and a 6.08% 1 year total...
NYSE:DOW
NYSE:DOWChemicals

Dow (DOW) Lands Mattress Testing Deal, Is The Stock Trading At A Discount?

Dow (DOW) is in focus after SweetNight selected the company and GoodBed to run independent mattress testing and consumer education, aiming to provide clearer performance data and build trust in mattress purchases. See our latest analysis for Dow. Dow's latest mattress testing partnership comes against a mixed share price backdrop, with the stock down 24.3% over the past 90 days, yet showing a 20.9% year to date share price return and a 45.5% 1 year total shareholder return. This points to...
NYSE:CR
NYSE:CRMachinery

What Crane (CR)'s Acquisition-Fueled Guidance Hike Means For Shareholders

In late July 2026, Crane Company reported second-quarter 2026 results showing sales rising to US$724.7 million and net income of US$95.9 million, alongside affirming a regular quarterly dividend of US$0.255 per share for payment on September 9, 2026. The company also raised its full-year 2026 sales growth guidance into the mid-20% range, highlighting acquisitions as a key driver of its expanded outlook. Now we’ll explore how Crane’s raised full-year sales guidance, driven by acquisitions,...
NasdaqGS:CSCO
NasdaqGS:CSCOCommunications

Cisco Stock And 2 AI Infrastructure Dividend Picks Worth A Closer Look

With the S&P 500 at record highs and valuations flashing similar signals to the late 1990s, many investors worry about where the next painful reset might land. Yet this is also when quality can matter most, as resilient dividend payers may stand out if lofty growth stories disappoint. This article walks through three stocks exposed to today’s AI driven enthusiasm and rich valuations, all drawn from a High-Quality Dividend Growth Stocks screener. The stocks covered below are just a starting...
NYSE:ASH
NYSE:ASHChemicals

Is Ashland (ASH) Using Its New Advisory Committee to Quietly Redefine Capital Allocation Priorities?

Ashland Inc. previously declared a quarterly cash dividend of US$0.42 per share, payable on September 15, 2026, to shareholders of record on September 1, 2026, alongside reporting third-quarter fiscal 2026 sales of US$497 million and net income of US$16 million. The company also reached a cooperation agreement with Ancora Holdings Group, adding two independent directors and forming a Capital Allocation Advisory Committee, potentially reshaping how Ashland thinks about investment priorities...
NasdaqGM:LGND
NasdaqGM:LGNDPharmaceuticals

Should Ligand Pharmaceuticals’ (LGND) Strong Q2 Profit Rebound and Reaffirmed 2026 Guidance Require Action From Investors?

In the past quarter, Ligand Pharmaceuticals reported second-quarter 2026 revenue of US$63.69 million, up from US$47.63 million a year earlier, with net income rising to US$48.51 million and diluted earnings per share from continuing operations reaching US$2.22. For the first half of 2026, Ligand moved from a net loss to net income and reaffirmed its full-year outlook for total revenue of US$270 million to US$310 million and GAAP net income of US$107 million to US$118 million, underscoring a...
NasdaqGS:MRVL
NasdaqGS:MRVLSemiconductor

Marvell Stock And 2 AI Infrastructure Names Linked To North American Chip Manufacturing

Nearshoring to Mexico has quietly reshaped how North American electronics and advanced manufacturing reach the U.S. market, with USMCA rules and tariff pressures on China pushing more tech supply chains south of the border. For investors, that shift creates a fresh set of potential winners and risks across hardware, chip and AI related manufacturing stocks. This article walks through three stocks from our screener that appear closely tied to this story today. The three stocks that follow are...
NasdaqGS:CNXN
NasdaqGS:CNXNElectronic

Record AI-Driven Quarter and Dividend Hike Might Change The Case For Investing In PC Connection (CNXN)

In late July 2026, PC Connection, Inc. reported second-quarter sales of US$854 million and net income of US$33.17 million, with earnings per share rising year on year, and the Board declared a US$0.20 quarterly dividend payable on August 28, 2026. The company highlighted record results supported by strong demand for enterprise AI solutions and technology modernization, including Windows 11 migrations, alongside record backlogs that underpin its operational momentum. We’ll now examine how...
NasdaqGS:ADPT
NasdaqGS:ADPTLife Sciences

Adaptive Biotechnologies (ADPT) Is Up 10.5% After Raising 2026 MRD Revenue Guidance Has The Bull Case Changed?

In the second quarter of 2026, Adaptive Biotechnologies reported sales of US$71.55 million, higher than a year earlier, alongside a wider net loss of US$39.79 million and a basic loss per share from continuing operations of US$0.25. Alongside these results, the company raised full-year 2026 revenue guidance for its MRD business to a range of US$268 million to US$278 million, signaling increased management confidence in that segment despite ongoing losses. Now, we will assess how the upgraded...
NasdaqGS:FOXA
NasdaqGS:FOXAMedia

Can Fox (FOXA) Hold Its Value After World Cup Led Growth?

Fox stock has almost doubled over the past three years, and after that kind of run the current share price near US$64 no longer looks obviously cheap or obviously expensive. The Discounted Cash Flow (DCF) intrinsic value estimate points to a price that is close to fair value, while the broader valuation checks and market multiples leave room for debate about how much upside is left. Fox has returned about 92.2% over the past three years, which puts recent gains at the center of any valuation...
NYSE:ACEL
NYSE:ACELHospitality

Is Accel Entertainment (ACEL) A Bargain As Earnings Growth Lifts Valuation Hopes?

Accel Entertainment (ACEL) is attracting fresh attention after its 4 August 2026 earnings update, which showed higher sales, revenue and net income for both the quarter and first half compared with the prior year. See our latest analysis for Accel Entertainment. At a share price of $12.16, Accel Entertainment has posted a 6.95% year to date share price return and a 10.34% 1 year total shareholder return, which suggests moderate positive momentum heading into the latest earnings and capital...
NasdaqGS:MCHB
NasdaqGS:MCHBBanks

Why Is Mechanics Bancorp (MCHB) Cutting Multifamily Real Estate Risk?

Mechanics Bancorp (NasdaqGS:MCHB) used its Q2 2026 earnings update to outline a reduction in multifamily real estate exposure, with a focus on rent regulated properties. Management detailed a shift in the loan book mix away from higher risk multifamily segments in response to evolving local regulations. The move contrasts with peers that are keeping or expanding multifamily exposure and highlights diverging risk views across regional banks. Shareholders and sector watchers now have clearer...
NYSE:ENOV
NYSE:ENOVMedical Equipment

Enovis (ENOV) Reaffirmed Guidance And Improved Margins, Is The Stock Still Undervalued?

Enovis (ENOV) drew fresh attention on 6 August 2026 after reaffirming its full year 2026 revenue guidance and releasing second quarter results that showed organic growth, margin improvement, and a smaller net loss. See our latest analysis for Enovis. At a share price of $26.61, Enovis has had a mixed run, with a 30 day share price return of 3.34% and a 90 day share price return of 7.38%. However, the 1 year total shareholder return declined 6.43%, suggesting some recent momentum after a...
NYSE:VIRT
NYSE:VIRTCapital Markets

Virtu Financial (VIRT) Could Be 13% Below Fair Value As Trading Income Jumps 31%

Dividend affirmation and trading income surge set the tone Virtu Financial (VIRT) recently caught investor attention after its board affirmed a quarterly cash dividend of $0.24 per share, alongside a 31% surge in trading income linked to higher market volatility. The company is also investing in infrastructure, hiring additional talent, and expanding its capital base with an upsized term loan, as it looks to capture trading opportunities across more asset classes. See our latest analysis for...
NYSE:HPQ
NYSE:HPQTech

HP (HPQ) Could Be 31% Overvalued As Momentum Tests Its Valuation

HP stock snapshot and recent performance HP (HPQ) has drawn fresh attention after recent trading, with the stock closing at $30.05 on 4 September 2025. Investors are weighing this level against the company’s recent and longer term return profile. Over the past day, HP has recorded a 6.64% move, with a 10.19% change over the past week. The stock shows a one-month return of 24.07% and a three-month return of 38.67%, while the one-year total return stands at 20.997%. See our latest analysis for...